Loading organizations...
§ Private Profile · Shenzhen, Guangdong, China
Developer of anti-cancer solutions addressing drug resistance.
TargetRx has raised $14.8M across 1 funding round.
TargetRx has raised $14.8M in total across 1 funding round.
TargetRx has raised $14.8M across 1 funding round. Most recently, it raised $14.8M Other Equity in September 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 19, 2020 | $14.8M Venture Round | Hongtai Fund | — | Announced |
TargetRx has raised $14.8M in total across 1 funding round.
TargetRx's investors include Hongtai Fund.